Our networking is in full swing for JPM2026!

We invite you to meet our team at the 2026 Annual Summit in San Francisco, January 11 -15, 2026. Robert Arch at JPM Biotech Showcase and Sachs Oncology Innovation Forum; Miguel Zubizarreta and Theresa Visarius at BIO Partnering.

Meeting with our team members in San Francisco will be an excellent opportunity to discuss our existing data, including encouraging clinical results from cancer patients treated with IP-001, and upcoming milestones. They are looking forward to fostering connections.

Immunophotonics is pioneering Interventional Immuno-Oncology®, an innovative approach that could transform routine tumor ablations into powerful immunotherapies with IP-001 turning every procedure into an opportunity to mobilize the body’s natural immune system against cancer.